https://insideevs.com/news/628539/california-bans-tesla-from-marketing-its-evs-as-full-self-driving/
Related Posts
BioCryst Gets FDA Fast Track Designation For Bone Formation Disorder Candidate
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BioCryst Pharmaceuticals's (NASDAQ: BCRX) lead drug candidate BCX9250 for the prevention of heterotopic ossification (HO) in patients with fibrodysplasia ossificans progressiva (FOP).
Morgan Stanley Maintains Overweight on Hyatt Hotels, Raises Price Target to $139
Morgan Stanley analyst Stephen Trent maintains Hyatt Hotels (NYSE:H) with a Overweight and raises the price target from $138 to $139.
Magenta Therapeutics Trims R&D, Cuts Workforce
Magenta Therapeutics Inc (NASDAQ:MGTA) is cutting 14% of staff and axing a planned dosing optimization trial for a stem…